Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors

Communications in Clinical Cytometry

Volumn 38, Issue 3, 1999, Pages 118-123

  Maillo A ^a   Diaz P ^a   Blanco, A ^a   Lopez A ^b   Ciudad, J ^b   Hernandez J ^a   Morales, F ^a   Perez Simon J A ^a   Orfao, A ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cell cycle; DNA content; Flow cytometry; Meningioma; Prognostic factors; S phase

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR CELL CULTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; DIPLOIDY; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; S PHASE; TUMOR CELLS, CULTURED;

ARACHNOIDEA;

EID: 0344171997     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990615)38:3<118::AID-CYTO5>3.0.CO;2-J     Document Type: Article

References (45)

1. Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983; 58:51-56.
2. Akachi K, Matsumoto M, Yassue M, Nakamura N, Kamada M, Ohno T. DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence. No Shinkei Geka 1991;19:1129-1134 [in Japanese].
3. Appley AJ, Fitzgibbons PL, Chandrasoma PT Hinton DR, Apuzzo MLJ. Multiparameter flow cytometric analysis of neoplasms of the central nervous system. Correlation of nuclear antigen p105 and DNA content with clinical behavior. Neurosurgery 1990;27:83-96.
4. Baird M, Gallagher PJ. Recurrent intracranial and spinal meningiomas: clinical and histological features. Clin Neuropathol 1989;8:41-44.
5. Borovich B, Doron Y. Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 1986;64:58-63.
6. Cantore G, Delfini R, Domenicucci M. Recurrence of intracranial meningioma. In: Schmidek HH, editor. Meningiomas and their surgical management. Philadelphia: W.U. Saunders; 1991. p 526-534.
7. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningiomas after surgical treatment. A quantitative approach. Acta Neuropathol (Berl) 1983;61:130-134.
8. Crompton MR, Gautier-Smith PC. The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 1970;33:80-87.
9. Crone KR, Challa VR, Kute TE, Moody DM, Kelly DL. Relationship between flow cytometric features and clinical behavior of meningiomas. Neurosurgery 1988;23:720-724.
10. Cruz-Sánchez FF, Miguel R, Rossi ML, Figols J, Palacin A, Cardesa A. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study. Histol Histopathol 1993;8:1-8.
11. De la Monte SM, Flickinger J, Linggood RM. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 1986;10:836-843.
12. Flinn WG, Goolsby CL, Rao MS. DNA flow cytometric analysis of hemangiopericytoma. Am J Clin Pathol 1994;101:181-185.
13. García García J, Muñoz de la Espada JB, Orfao de Matos A, Ciudad PizarroJ, Gomez Alonso A. Correlación clinico-biológica y caracteristicas del ADN en 74 pacientes con cancer colorrectal (citometria de flujo de piezas en fresco). Cir Esp 1992;51:16-20.
14. García R, Bueno A, Castañón S, Ruiz-Barnes P, Maria de Campos J, Kusak E, Fortes JR, Ortiz F, Sarasa JL. Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. Oncology 1997;54:112-117.
15. Hoshino T, Nomura K, Wilson CB, Knebel KD, Gray JW. The distribution of nuclear DNA from human brain-tumor cells: flow cytometric studies. J Neurosurg 1978;49:13-21.
16. Ironside JW, Battersby RD, Lawry J, Loomes RS, Day CA, Timperley WR. DNA in meningioma tissues and explant cell cultures: a flow cytometric study with clinicopathological correlates. J Neurosurg 1987;66:588-594.
17. Jaaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986;26:461-469.
18. Jaaskelainen J, Haltia M, Kallio M. Recurrence of histologically benign meningioma after seemingly complete removal In: Schmidek HH, editor. Meningiomas and their surgical management. Philadelphia: W.B. Saunders; 1991. p 517-525.
19. Jellinger K, Slowik F. Histologic subtypes and pronostic problems in meningiomas. J Neurol 1975;208:279-298.
20. Kajiwara K, Fudaba H, Tsuha M, Ueda H, Mitani T, Nishizaki T, Aoki H. Analysis of recurrence of meningiomas following neurosurgical resection. No Shinkei Geka 1989;17:1125-1131 [in Japanese].
21. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 1992;31:2-12.
22. Kawamoto K, Herz F, Wolley RC, Hirano A, Kajikawa H, Koss G. Flow cytometric analysis of the DNA distribution in human brain tumors. Acta Neuropathol (Berl) 1979;46:39-44.
23. Kepes JJ. Meningiomas: biology, pathology and differential diagnosis. New York: Masson Publishing USA, Inc., 1982. p 116-149.
24. Kujas M, Rateau JG, Bruch JF, Van Effenterre R. Apport de la cytometrié en flux dans l'étude des meningiomes. Resultats preliminaires et essai de correlation cliníque. Arch Anat Cytol Pathol 1996;44:77-82.
25. Laerum OK, Farsund T. Clinical application of flow cytometry. A review. Cytometry 1981;2:1-13.
26. Marks SM, Whitwell HL, Lye RM. Recurrence of meningiomas after operation. Surg Neurol 1986;25:436-440.
27. May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE. The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 1989;71:347-351
28. Meixensberger J, Janka M, Zellner A, Roggendorf W, Roosen K. Prognostic significance of nuclear DNA content in human meningiomas: a prospective study. Acta Neurochir [Suppl] (Wien) 1996;65:70-72.
29. Miller DC. Predicting recurrence of intracranial meningiomas. Neurosurg Clin North Am 1994;5:193-200.
30. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann R, Martuza R. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.
31. Nishizaki T, Orita T, Kajiwara K, Ikeda N, Ohshita N, Nakayama H, Furutani Y, Ikeyama Y, Akimura T, Kamiryo T, Ito H. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival recurrence in brain-tumor patients J Neurosurg 1990;73:396-400.
32. Ormerod MG, Tribukait B, Giaretti W. Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. Anal Cell Pathol 1999; in press.
33. Paz-Bouza JI, Orfao A, Abad MM, Ciudad J, García MC, López A, Bullon A. Transrectal fine needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies. Pathol Res Pract 1994;190:682-689.
34. Rorhinger M, Southerland GR, Louw DF, Sima AAF. Incidence and clinicopathological features of meningioma J Neurosurg 1989;71:665-672.
35. Rubinstein LJ. Tumors on the central nervous system: atlas of tumor pathology, series 2, fascicle 6. Washington, DC: Armed Forces Institute of Pathology; 1972. p 169-189.
36. Russell DS, Rubinstein LJ. Pathology of tumors of the nervous system, 4th ed. London: Edward Arnold; 1977. p 66-91.
37. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Medley DW, Mayall BH, Wheeless L. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-477.
38. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psyichiatry 1957;20:22-39.
39. Skullerud K, Löken AC. The prognosis in meningiomas. Acta Neuropathol (Berl) 1974;29:337-344.
40. Spaar FW, Ahyai A, Blech M. DNA-fluorescence-cytometry and prognosis (grading) of meningiomas. A study of 104 surgically removed tumors. Neurosurg Rev 1987;10:35-39.
41. Thomas HG, Dolman CL, Berry K. Malignant meningioma: clinical and pathological features. J Neurosurg 1981;55:929-934.
42. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-327.
43. Waga S, Yatmashita J, Handa H. Recurrence of meningiomas. Neurol Med Chir (Tokyo) 1977;17:2003-2208.
44. Yasue M, Akasaki Y, Numoto TR, Abe S, Takeuchi Y, Tanaka J. MIB-1 immunostaining and DNA flow cytometry in meningiomas. Noshuyo Byori 1996;13:17-20.
45. Zulch KJ, editor. Histologic typing of tumors of the central nervous system. International histological classification of tumors, no 21.Geneva: World Health Organization; 1979. p 53-56.